Concepedia

Steven L. Yoder

SL

Statistics

Publications

5

Citations

119

H-Index

5

Active since

1991

Affiliations

Michigan Medicine(Current)

Io Therapeutics (United States)

Steven L. Yoder is an author at Michigan Medicine specializing in fluoroquinolone antibiotics, antibacterial pharmacology, and pharmacology.

Publications per year

1991–1995

5

Publications

5

In vitro antibacterial activities of PD 131628, a new 1,8-naphthyridine anti-infective agent

Michael Cohen, Michael D. Huband, Gail B. Mailloux et al. · Antimicrobial Agents and Chemotherapy · 1991 · 33 citations · Full text

, , +11

In vitro and in vivo activities of clinafloxacin, CI-990 (PD 131112), and PD 138312 versus enterococci

Michael Cohen, Steven L. Yoder, Michael D. Huband et al. · Antimicrobial Agents and Chemotherapy · 1995 · 31 citations · Full text

, , +14

In vitro antibacterial activities of the fluoroquinolones PD 117596, PD 124816, and PD 127391

Michael Cohen, Michael D. Huband, Gail B. Mailloux et al. · Diagnostic Microbiology and Infectious Disease · 1991 · 30 citations

, , +10

In vitro activity of sparfloxacin (CI-978, AT-4140, and PD 131501)

Michael Cohen, Michael D. Huband, Gail B. Mailloux et al. · Diagnostic Microbiology and Infectious Disease · 1991 · 14 citations

, , +8

In vitro antibacterial activities of PD 138312 and PD 140248, new fluoronaphthyridines with outstanding gram-positive potency

Michael D. Huband, Michael Cohen, Mark A. Meservey et al. · Antimicrobial Agents and Chemotherapy · 1993 · 11 citations

, , +12

1–5 of 5